论文部分内容阅读
2014年12月~2015年12月期间,收治心衰合并心律失常患者74例,所有患者均接受胺碘酮进行治疗,随机法分为对照组37例,采用常规护理,观察组37例,采用优质护理。结果:在实施不同护理干预前,两组患者血压及心率并无显著差异(P>0.05),在实施护理干预后,两组患者血压及心率均较之前有明显改善(P<0.05),观察组高于对照组(P<0.05)。护理满意度上,对照组远不及观察组(78.38%<97.30%)(P<0.05)。结论:通过为心衰合并心律失常患者提供胺碘酮治疗+优质护理服务,可使患者临床病症得到显著改善,提升其临床治疗效果。
Between December 2014 and December 2015, 74 patients with heart failure and arrhythmia were enrolled. All patients were treated with amiodarone. Randomly divided into control group (n = 37), routine nursing group (n = 37) and observation group Quality care. Results: Before the implementation of different nursing interventions, there was no significant difference in blood pressure and heart rate between the two groups (P> 0.05). After nursing intervention, the blood pressure and heart rate were significantly improved in both groups (P <0.05) Group than in the control group (P <0.05). In nursing satisfaction, the control group was far less than the observation group (78.38% <97.30%) (P <0.05). Conclusions: By providing amiodarone treatment and quality nursing services to patients with heart failure and arrhythmia, the clinical symptoms of patients can be significantly improved and the clinical treatment effect can be improved.